106 related articles for article (PubMed ID: 3585908)
1. Spectroscopic detection of iminocyclophosphamide and its possible role in cyclophosphamide metabolism.
Kwon CH; Kirk MC; Struck RF; Borch RF
J Med Chem; 1987 Jun; 30(6):1110-4. PubMed ID: 3585908
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. 2. Direct observation, characterization, and reactivity studies of iminocyclophosphamide and related species.
Boyd VL; Summers MF; Ludeman SM; Egan W; Zon G; Regan JB
J Med Chem; 1987 Feb; 30(2):366-74. PubMed ID: 3806617
[TBL] [Abstract][Full Text] [Related]
3. Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism.
Kwon CH; Borch RF; Engel J; Niemeyer U
J Med Chem; 1987 Feb; 30(2):395-9. PubMed ID: 3806619
[TBL] [Abstract][Full Text] [Related]
4. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
Fenselau C; Lehman JP; Myles A; Brandt J; Yost GS; Friedman OM; Colvin OM
Drug Metab Dispos; 1982; 10(6):636-40. PubMed ID: 6130913
[TBL] [Abstract][Full Text] [Related]
5. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
6. Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate.
Borch RF; Getman KM
J Med Chem; 1984 Apr; 27(4):485-90. PubMed ID: 6708050
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of activation of 4-hydroxycyclophosphamide.
Borch RF; Millard JA
J Med Chem; 1987 Feb; 30(2):427-31. PubMed ID: 3806624
[TBL] [Abstract][Full Text] [Related]
8. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
[TBL] [Abstract][Full Text] [Related]
9. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR
J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the behaviour of 4-ketocyclophosphamide versus cyclophosphamide during capillary gas chromatography by mass spectrometry.
de Bruijn EA; van Oosterom AT; Leclercq PA; de Haan JW; van de Ven LJ; Tjaden UR
Biomed Environ Mass Spectrom; 1987 Nov; 14(11):643-7. PubMed ID: 2962671
[TBL] [Abstract][Full Text] [Related]
12. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
[TBL] [Abstract][Full Text] [Related]
13. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
[TBL] [Abstract][Full Text] [Related]
14. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
Borch RF; Hoye TR; Swanson TA
J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative investigations of cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and related compounds by field-desorption mass spectrometry.
Schulten HR
Cancer Treat Rep; 1976 Apr; 60(4):501-7. PubMed ID: 1277227
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
Sonawat HM; Leibfritz D; Engel J; Hilgard P
Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593
[TBL] [Abstract][Full Text] [Related]
17. Structures of two isomeric bicyclic derivatives of 4-hydroperoxyisophosphamide.
Camerman N; Fawcett JK; Camerman A
J Med Chem; 1983 May; 26(5):683-6. PubMed ID: 6842508
[TBL] [Abstract][Full Text] [Related]
18. Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.
Jarman M; Milsted RA; Smyth JF; Kinas RW; Pankiewicz K; Stec WJ
Cancer Res; 1979 Jul; 39(7 Pt 1):2762-7. PubMed ID: 445480
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides.
Peter G; Hohorst HJ
Cancer Chemother Pharmacol; 1979; 3(3):181-8. PubMed ID: 527208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
